In CML, BCR-ABL compromises the fidelity of nucleotide excision repair and homologous recombination repair, thus promoting survival and resulting in the genomic instability of CML cells, especially LSCs11,58–60. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.